Habib Syed S, Alzoghaibi Mohammed A, Abba Abdullah A, Hasan Mujtaba
Department of Physiology (29), College of Medicine, PO Box 2925, King Saud University, Riyadh 11461, Kingdom of Saudi Arabia. Tel. +966 (11) 4671604. Fax. +966 (11) 4672567. E-mail:
Saudi Med J. 2014 Apr;35(4):397-402.
To determine the relationship between the asthma control test (ACT) score using the Arabic version, fractional exhaled nitric oxide (FENO), and lung functions, and to derive the cutoff points for the ACT score with the American Thoracic Society recommended FENO standard levels of inflammation control.
We recruited 59 adult asthmatics out of which 53 subjects completed the study between July 2011 and June 2012 at King Saud University, Riyadh, Saudi Arabia. The FENO levels were measured by NIOX MINO (Aerocrine AB, Solna, Sweden), and ventilatory functions were recorded by standard techniques.
The FENO values were significantly higher in patients with an ACT score <20 (65.5+/= 35.4) compared with those patients with an ACT score >/= 20 (27.4+/=10.5, p<0.001). Among the well-controlled group based on the ACT score criteria, 6 (25%) cases had high FENO levels, while among the poorly controlled group, 23 (79.3%) cases had high FENO levels (odds ratio: 11.5; p<0.0001; confidence interval: 3.16-41.72). There was a significant negative correlation between FENO and ACT score (r=-0.581, p<0.0001). At the international cutoff point of 20, the sensitivity was 95.2, and the specificity was 68.8. The receiver operating curve (ROC) showed that maximum sensitivity and specificity were observed at an ACT score cut off point of 19 (sensitivity: 90.5, and specificity: 81.2).
The FENO levels correlate negatively with ACT scores however, the relationship between FENO and lung function is not significant. A significant relationship between ACT score and FENO levels indicate that there is an ongoing inflammatory state in patients with poor asthma control.
确定使用阿拉伯语版本的哮喘控制测试(ACT)分数、呼出一氧化氮分数(FENO)与肺功能之间的关系,并根据美国胸科学会推荐的FENO炎症控制标准水平得出ACT分数的截断点。
我们招募了59名成年哮喘患者,其中53名受试者于2011年7月至2012年6月在沙特阿拉伯利雅得的沙特国王大学完成了研究。FENO水平通过NIOX MINO(瑞典索尔纳的Aerocrine AB公司)测量,通气功能通过标准技术记录。
与ACT分数≥20的患者(27.4±10.5)相比,ACT分数<20的患者(65.5±35.4)的FENO值显著更高(p<0.001)。在基于ACT分数标准的控制良好组中,6例(25%)患者FENO水平较高,而在控制不佳组中,23例(79.3%)患者FENO水平较高(优势比:11.5;p<0.0001;置信区间:3.16 - 41.72)。FENO与ACT分数之间存在显著负相关(r = -0.581,p<0.0001)。在国际截断点20时,敏感性为95.2,特异性为68.8。受试者工作特征曲线(ROC)显示,在ACT分数截断点为19时观察到最大敏感性和特异性(敏感性:90.5,特异性:81.2)。
FENO水平与ACT分数呈负相关,然而,FENO与肺功能之间的关系不显著。ACT分数与FENO水平之间的显著关系表明哮喘控制不佳的患者存在持续的炎症状态。